Review



mouse rm-9 prostate cancer cells  (Jackson Laboratory)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Jackson Laboratory mouse rm-9 prostate cancer cells
    Mouse Rm 9 Prostate Cancer Cells, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse rm-9 prostate cancer cells/product/Jackson Laboratory
    Average 90 stars, based on 1 article reviews
    mouse rm-9 prostate cancer cells - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    rm 9 mouse prostate cancer cells  (ATCC)
    94
    ATCC rm 9 mouse prostate cancer cells
    Rm 9 Mouse Prostate Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rm 9 mouse prostate cancer cells/product/ATCC
    Average 94 stars, based on 1 article reviews
    rm 9 mouse prostate cancer cells - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    mouse prostate cancer cell line rm  (ATCC)
    94
    ATCC mouse prostate cancer cell line rm
    Mouse Prostate Cancer Cell Line Rm, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse prostate cancer cell line rm/product/ATCC
    Average 94 stars, based on 1 article reviews
    mouse prostate cancer cell line rm - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    rm9 murine prostate cancer cells  (ATCC)
    94
    ATCC rm9 murine prostate cancer cells
    Impact of vanadyl sulfate plus NDV combination therapy in a subcutaneous <t>RM9</t> mouse model Male C57BL/6 mice were administered syngeneic 1 × 10 5 RM9 prostate cancer cells subcutaneously. Seven days later, mice received phosphate-buffered saline (i.t.), vanadyl sulfate (40 mg/kg; i.t.), NDV (5.0 × 10 7 PFU; i.t.) or vanadyl sulfate intraperitoneally (i.p.) 4 h prior to i.t. administration of NDV. Mice were euthanized when tumors reached 15 mm in any one direction. Significance was determined using log rank (Mantel-Cox) test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001).
    Rm9 Murine Prostate Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rm9 murine prostate cancer cells/product/ATCC
    Average 94 stars, based on 1 article reviews
    rm9 murine prostate cancer cells - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    mouse rm-9 prostate cancer cells  (Jackson Laboratory)
    90
    Jackson Laboratory mouse rm-9 prostate cancer cells
    Impact of vanadyl sulfate plus NDV combination therapy in a subcutaneous <t>RM9</t> mouse model Male C57BL/6 mice were administered syngeneic 1 × 10 5 RM9 prostate cancer cells subcutaneously. Seven days later, mice received phosphate-buffered saline (i.t.), vanadyl sulfate (40 mg/kg; i.t.), NDV (5.0 × 10 7 PFU; i.t.) or vanadyl sulfate intraperitoneally (i.p.) 4 h prior to i.t. administration of NDV. Mice were euthanized when tumors reached 15 mm in any one direction. Significance was determined using log rank (Mantel-Cox) test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001).
    Mouse Rm 9 Prostate Cancer Cells, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse rm-9 prostate cancer cells/product/Jackson Laboratory
    Average 90 stars, based on 1 article reviews
    mouse rm-9 prostate cancer cells - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    rm-9 prostate cells  (Jackson Laboratory)
    90
    Jackson Laboratory rm-9 prostate cells
    Impact of vanadyl sulfate plus NDV combination therapy in a subcutaneous <t>RM9</t> mouse model Male C57BL/6 mice were administered syngeneic 1 × 10 5 RM9 prostate cancer cells subcutaneously. Seven days later, mice received phosphate-buffered saline (i.t.), vanadyl sulfate (40 mg/kg; i.t.), NDV (5.0 × 10 7 PFU; i.t.) or vanadyl sulfate intraperitoneally (i.p.) 4 h prior to i.t. administration of NDV. Mice were euthanized when tumors reached 15 mm in any one direction. Significance was determined using log rank (Mantel-Cox) test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001).
    Rm 9 Prostate Cells, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rm-9 prostate cells/product/Jackson Laboratory
    Average 90 stars, based on 1 article reviews
    rm-9 prostate cells - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    subconfluent mouse rm 9 prostate cancer cells  (ATCC)
    94
    ATCC subconfluent mouse rm 9 prostate cancer cells
    Impact of vanadyl sulfate plus NDV combination therapy in a subcutaneous <t>RM9</t> mouse model Male C57BL/6 mice were administered syngeneic 1 × 10 5 RM9 prostate cancer cells subcutaneously. Seven days later, mice received phosphate-buffered saline (i.t.), vanadyl sulfate (40 mg/kg; i.t.), NDV (5.0 × 10 7 PFU; i.t.) or vanadyl sulfate intraperitoneally (i.p.) 4 h prior to i.t. administration of NDV. Mice were euthanized when tumors reached 15 mm in any one direction. Significance was determined using log rank (Mantel-Cox) test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001).
    Subconfluent Mouse Rm 9 Prostate Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/subconfluent mouse rm 9 prostate cancer cells/product/ATCC
    Average 94 stars, based on 1 article reviews
    subconfluent mouse rm 9 prostate cancer cells - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    rm 9 prostate tumor cells  (ATCC)
    94
    ATCC rm 9 prostate tumor cells
    Impact of vanadyl sulfate plus NDV combination therapy in a subcutaneous <t>RM9</t> mouse model Male C57BL/6 mice were administered syngeneic 1 × 10 5 RM9 prostate cancer cells subcutaneously. Seven days later, mice received phosphate-buffered saline (i.t.), vanadyl sulfate (40 mg/kg; i.t.), NDV (5.0 × 10 7 PFU; i.t.) or vanadyl sulfate intraperitoneally (i.p.) 4 h prior to i.t. administration of NDV. Mice were euthanized when tumors reached 15 mm in any one direction. Significance was determined using log rank (Mantel-Cox) test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001).
    Rm 9 Prostate Tumor Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rm 9 prostate tumor cells/product/ATCC
    Average 94 stars, based on 1 article reviews
    rm 9 prostate tumor cells - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Impact of vanadyl sulfate plus NDV combination therapy in a subcutaneous RM9 mouse model Male C57BL/6 mice were administered syngeneic 1 × 10 5 RM9 prostate cancer cells subcutaneously. Seven days later, mice received phosphate-buffered saline (i.t.), vanadyl sulfate (40 mg/kg; i.t.), NDV (5.0 × 10 7 PFU; i.t.) or vanadyl sulfate intraperitoneally (i.p.) 4 h prior to i.t. administration of NDV. Mice were euthanized when tumors reached 15 mm in any one direction. Significance was determined using log rank (Mantel-Cox) test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001).

    Journal: Molecular Therapy Oncolytics

    Article Title: Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models

    doi: 10.1016/j.omto.2021.01.009

    Figure Lengend Snippet: Impact of vanadyl sulfate plus NDV combination therapy in a subcutaneous RM9 mouse model Male C57BL/6 mice were administered syngeneic 1 × 10 5 RM9 prostate cancer cells subcutaneously. Seven days later, mice received phosphate-buffered saline (i.t.), vanadyl sulfate (40 mg/kg; i.t.), NDV (5.0 × 10 7 PFU; i.t.) or vanadyl sulfate intraperitoneally (i.p.) 4 h prior to i.t. administration of NDV. Mice were euthanized when tumors reached 15 mm in any one direction. Significance was determined using log rank (Mantel-Cox) test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001).

    Article Snippet: DF-1 chicken embryo fibroblast cells (ATCC CRL-12203), B16-F10 murine melanoma cells (ATCC CRL-6475), and RM9 murine prostate cancer cells (ATCC CRL-3312) were purchased from ATCC.

    Techniques: Saline